Clinical Research & Trials
- Penicillin injection adherence for rheumatic heart disease had been a problem. After 3 uses in a special clinic for non-adherent patients, pain and fear dropped by half. Since adherence was much improved, the special clinic was disbanded.
- Buzzy was added to the National Guidelines for needle pain in New Zealand.
Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. J Paediatr Child Health. 2014;50(2):112-117. doi:10.1111/jpc.12400
Meta-Analyses: Pain Care Labs Technology the most effective IV and injection pain intervention, 50+ Independent Clinical Trials.
- “The Buzzy intervention should be used when children are undergoing IM injections to reduce their levels of pain and fear.” – Yilmaz et al.
- For adults receiving IM Diclofenac, Buzzy reduced pain 74% and satisfaction with the injection was 95 v. 84. P<.001 – Sahin et al
Ballard A Khadra C, Adler S, Doyon-Trottier E, Le May S. Efficacy of the Buzzy Device for Pain Management during Needle-Related Procedures: A Systematic Review and Meta-analysis. Clin J Pain. 2019 Feb 28 (N= 1138, pain reduction -1.11; 95% confidence interval [CI]: -1.52 to -0.70; P<0.0001) , anxiety reduction (SMD -1.37; 95% CI: -1.77 to 0.96; P<0.00001)